7DT3
Crystal structure of human transthyretin in complex with 4-chloro-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PHOTON FACTORY BEAMLINE BL-17A |
Synchrotron site | Photon Factory |
Beamline | BL-17A |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2018-11-29 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.98 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 42.029, 85.773, 63.708 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 31.854 - 1.198 |
R-factor | 0.1666 |
Rwork | 0.166 |
R-free | 0.18650 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4n85 |
RMSD bond length | 0.005 |
RMSD bond angle | 0.846 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHENIX |
Refinement software | PHENIX ((1.12-2829_1069: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 42.890 | 1.240 |
High resolution limit [Å] | 1.198 | 1.198 |
Rmeas | 0.056 | 0.668 |
Rpim | 0.022 | 0.301 |
Number of reflections | 71443 | 5753 |
<I/σ(I)> | 16.3 | 2.6 |
Completeness [%] | 97.8 | |
Redundancy | 6.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 293 | PEG400, CaCl2, sodium acetate |